Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Report 2026

Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Overview

• Respiratory Devices And Equipment (Therapeutic And Diagnostic) market size has reached to $13.62 billion in 2025 • Expected to grow to $27.1 billion in 2030 at a compound annual growth rate (CAGR) of 15.3% • Growth Driver: Growing Prevalence Of Respiratory Diseases Boosts Demand For Respiratory Devices And Equipment (Diagnostic) Market • Market Trend: Leading Companies Drive Innovation With Cutting-Edge Products Like The Vitalopft Series In The Respiratory Devices And Equipment Market • Asia-Pacific was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market?

Respiratory devices and equipment (therapeutic and diagnostic) are used to provide medication or assist a patient who is having difficulty in breathing and cannot achieve adequate oxygen levels to maintain life. Patients with respiratory disorders such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and acute respiratory distress syndrome require respiratory devices. The main types of respiratory devices and equipment are diagnostic devices, therapeutic devices, and monitoring devices. The diagnostic devices are used to diagnose respiratory-related issues. The various therapeutic devices are humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, and others. The diagnostic devices involved are spirometer, polysomnography, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers. These provide applications in chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea (OSA), respiratory distress syndrome (RDS), cystic fibrosis, and pneumonia. These are used by hospitals, clinics, home care settings, and ambulatory service centres.

What Is The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Growth Forecast?

The respiratory devices and equipment (therapeutic and diagnostic) market size is expected to see rapid growth in the next few years. It will grow to $27.1 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to growing demand for homecare respiratory solutions, increasing adoption of connected respiratory devices, expansion of tele-respiratory care services, rising investments in advanced ventilatory technologies, continued focus on patient-centric respiratory management. Major trends in the forecast period include increasing adoption of integrated diagnostic and therapeutic respiratory systems, rising deployment of home-based respiratory care devices, growing use of smart ventilation and oxygen therapy equipment, expansion of continuous respiratory monitoring solutions, enhanced focus on chronic respiratory disease management.

Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Segmentation

1) By Type: Diagnostic devices, Therapeutic devices, Monitoring devices 2) By Application: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis, Pneumonia 3) By End User: Hospitals, Clinics, Homecare settings, Ambulatory service centers Subsegments: 1) By Diagnostic Devices: Spirometers, Pulse Oximeters, Arterial Blood Gas (ABG) Analyzers, Capnometers, Peak Flow Meters 2) By Therapeutic Devices: Nebulizers, Inhalers (Metered-Dose Inhalers, Dry Powder Inhalers), Positive Airway Pressure (PAP) Devices, Oxygen Concentrators, Ventilators 3) By Monitoring Devices: Respiratory Rate Monitors, Blood Oxygen Saturation Monitors, Capnography Monitors, Pulmonary Function Monitors

What Is The Driver Of The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market?

The increasing prevalence of various respiratory diseases is expected to propel the growth of the respiratory devices and equipment (therapeutic and diagnostic) market going forward. Respiratory diseases are medical conditions that affect the lungs and airways, impairing normal breathing and oxygen exchange due to inflammation, infection, obstruction, or chronic structural damage. The increasing prevalence of various respiratory diseases is due to a growing global burden of conditions that progressively impair lung function and make populations more vulnerable to long-term respiratory complications. Respiratory devices and equipment support the management of respiratory diseases by improving airflow, enhancing oxygen delivery, and enabling more effective monitoring of lung function to stabilize patient health. For instance, in June 2025, according to World Health Organization, a Switzerland-based organization, 81.7 million people are living with a chronic respiratory diseases and 6.8 million are newly diagnosed each year. Therefore, the increasing prevalence of various respiratory diseases drives the respiratory devices and equipment (therapeutic and diagnostic) industry.

Key Players In The Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market

Major companies operating in the respiratory devices and equipment (therapeutic and diagnostic) market are Smiths Medical Inc., Philips Healthcare, GE Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Koninklijke Philips N.V., Dragerwerk AG, Medtronic plc, Masimo Corp., CareFusion Corporation, Compumedics Limited, Becton Dickinson and Company, Hamilton Medical, Mindray Medical International Limited, Vyaire Medical Inc., Getinge AB, AirSep Corporation, Breas Medical AB, Hill-Rom Holdings Inc., Inogen, Shenzhen Mindray Bio-Medical Electronics Co., Linde plc, DeVilbiss Healthcare LLC, Nihon Kohden Corporation, Nonin Medical Inc., O2 Concepts LLC, Precision Medical Inc., Pulmodyne Inc., Salter Labs Inc., Sechrist Industries Inc., Teleflex Inc., Ventec Life Systems, VitalAire, Weinmann Emergency Medical Technology GmbH + Co. KG, ZOLL Medical Corporation

Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Trends and Insights

Major companies operating in the respiratory devices and equipment (therapeutic and diagnostic) market are innovating new technological products such as VitaloPFT series to increase their profitability in the market. The VitaloPFT Series is a range of pulmonary function testing devices. For instance, in March 2023, Vitalograph Ltd., a US-based respiratory medical devices company launched respiratory VitaloPFT series. The series is created to provide high-quality, accurate, and dependable respiratory medical equipment and services and is intended for use in secondary care. Hospitals and other secondary care facilities that require complicated respiratory diagnostic solutions can receive advanced respiratory diagnostic solutions from the VitaloPFT Series.

What Are Latest Mergers And Acquisitions In The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market?

In June 2023, SunMed Group Holdings, LLC, a Canada-based manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, acquired Avanos Medical, Inc.’s Respiratory Health business for US$ 110 million. With this acquisition, SunMed aims to strengthen its respiratory care consumables portfolio by adding Avanos’s established BALLARD, MICROCUFF, and endOclear product lines. Avanos, is a US-based medical device company, known for its respiratory consumables and catheter products.

Regional Outlook

Asia-Pacific was the largest region in respiratory devices and equipment (therapeutic and diagnostic) market in 2025. Western Europe was the second-largest region in respiratory devices and equipment (therapeutic and diagnostic) market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market?

The respiratory devices and equipment (therapeutic and diagnostic) market consists of sales of instruments such as humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, spirometer, polysomnographs, peak flow meters, pulse oximeters, capnographs, and gas analyzers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.